Conversio Health Albuterol Vial Recall: Lack of Processing Controls Hazard
Conversio Health recalls albuterol inhaler vials due to lack of processing controls. All lots affected. No specific remedy stated in official notice.
Recall notice
Lack of Processing Controls
Contact the company
What happened, in plain English
Conversio Health is recalling all vials of albuterol 2.5mg with ipratropium 0.75mg and triamcinolone 0.5mg for inhalation. The recall is due to a lack of processing controls that could affect product safety. Read more at govinfonow.com/recall/37711-conversio-health-albuterol-vial-recall-lack-of-processing-controls-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/37711-conversio-health-albuterol-vial-recall-lack-of-processing-controls-hazard · Updated October 5, 2026 · FDA enforcement record: FDA #D-0516-2020
Cite this page
“Conversio Health Albuterol Vial Recall: Lack of Processing Controls Hazard.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37711-conversio-health-albuterol-vial-recall-lack-of-processing-controls-hazard. Based on FDA recall #D-0516-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0516-2020%22&limit=1).
Why it’s dangerous
The lack of processing controls means the medication may not be manufactured safely, potentially leading to inconsistent dosing or contamination. This could cause ineffective treatment or adverse reactions.
Who’s affected
All owners of the recalled vials, particularly those using inhalers for asthma or COPD. People with respiratory conditions are at higher risk.
How to tell if you have this one
Check for vials labeled 'Albuterol 2.5mg / Ipratropium 0.75mg/ Triamcinolone 0.5 mg 3ML Vial, For Inhalation Only' from Conversio Health. All lots are affected.
- Brand
Conversio Health- Category
Drug
All 10 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide in the U.S.
| Recall number | Product, codes & lots |
|---|---|
| D-0507-2020 | Formoterol 12mcg / Budesonide 0.5mg, 3.5ML Vial, For Inhalation Only, Shake Well, Conversio Health, San Luis Obispo, CA 93401.; All Lots |
| D-0508-2020 | Budesonide 0.4mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.; All Lots |
| D-0509-2020 | Albuterol 3.75mg / Ipratropium 0.75mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.; All Lots |
| D-0510-2020 | Albuterol 2.5mg / Ipratropium 0.75mg, 2ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.; All Lots |
| D-0511-2020 | Albuterol 2.5mg / Ipratropium 0.75mg /Budesonide 0.5mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.; All Lots |
| D-0512-2020 | Albuterol 2.5mg / Ipratropium 0.75mg /Budesonide 0.25mg, 3ML Vial, For Inhalation Only, Shake Well, Conversio Health, San Luis Obispo, CA 93401.; All lots |
| D-0513-2020 | Albuterol 2.5mg / Budesonide 0.5mg, 3ML Vial, For Inhalation Only, Shake Well, Conversio Health, San Luis Obispo, CA 93401.; All Lots |
| D-0514-2020 | Albuterol 1.25mg / Ipratropium 0.5mg/ Budesonide 0.25mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.; All lots |
| D-0515-2020 | Albuterol 1.25mg / Ipratropium 0.5mg, 2ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.; All lots |
| D-0516-2020 | Albuterol 2.5mg / Ipratropium 0.75mg/ Triamcinolone 0.5 mg 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.; All lots |
What to do — step by step
Check Product Details
Verify the vial label matches the recalled product description.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0516-2020 (November 12, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0516-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.